Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 2, Pages 531-539Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI64595
Keywords
-
Categories
Funding
- Human Frontiers Science Program (HFSP)
- John Simon Guggenheim Memorial Foundation
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
- Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- National Institute for Translational Neuroscience
Ask authors/readers for more resources
Alzheimer's disease (AD) and diabetes are currently considered among the top threats to human health worldwide. Intriguingly, a connection between these diseases has been established during the past decade, since insulin resistance, a hallmark of type 2 diabetes, also develops in Alzheimer brains. In this article, the molecular and cellular mechanisms underlying defective brain insulin signaling in AD are discussed, with emphasis on evidence that Alzheimer's and diabetes share common inflammatory signaling pathways. I put forward here a hypothesis on how a cross-talk between peripheral tissues and the brain might influence the development of AD, and highlight important unanswered questions in the field. Furthermore, I discuss a rational basis for the use of antidiabetic agents as novel and potentially effective therapeutics in AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available